
The global market for Image-based FFR Diagnosis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Image-based FFR Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Image-based FFR Diagnosis by region & country, by Type, and by Application.
The Image-based FFR Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Image-based FFR Diagnosis.
Market Segmentation
By Company
HeartFlow
Medis QFR
Beijing Heart Century
RainMed
AITROX
Keya Medical
Beijing GuanShengYun
ShengShi
Shenzhen Escope Tech
Pulse Medical Imaging
Shukun
Raysight
Cathworks
Segment by Type:
CT-FFR
QFR
OFR
Segment by Application
Hospital
Imaging Center
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Image-based FFR Diagnosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Image-based FFR Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Image-based FFR Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Image-based FFR Diagnosis Product Introduction
1.2 Global Image-based FFR Diagnosis Market Size Forecast
1.3 Image-based FFR Diagnosis Market Trends & Drivers
1.3.1 Image-based FFR Diagnosis Industry Trends
1.3.2 Image-based FFR Diagnosis Market Drivers & Opportunity
1.3.3 Image-based FFR Diagnosis Market Challenges
1.3.4 Image-based FFR Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Image-based FFR Diagnosis Players Revenue Ranking (2023)
2.2 Global Image-based FFR Diagnosis Revenue by Company (2019-2024)
2.3 Key Companies Image-based FFR Diagnosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Image-based FFR Diagnosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Image-based FFR Diagnosis
2.6 Image-based FFR Diagnosis Market Competitive Analysis
2.6.1 Image-based FFR Diagnosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Image-based FFR Diagnosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Image-based FFR Diagnosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CT-FFR
3.1.2 QFR
3.1.3 OFR
3.2 Global Image-based FFR Diagnosis Sales Value by Type
3.2.1 Global Image-based FFR Diagnosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Image-based FFR Diagnosis Sales Value, by Type (2019-2030)
3.2.3 Global Image-based FFR Diagnosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Imaging Center
4.2 Global Image-based FFR Diagnosis Sales Value by Application
4.2.1 Global Image-based FFR Diagnosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Image-based FFR Diagnosis Sales Value, by Application (2019-2030)
4.2.3 Global Image-based FFR Diagnosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Image-based FFR Diagnosis Sales Value by Region
5.1.1 Global Image-based FFR Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Image-based FFR Diagnosis Sales Value by Region (2019-2024)
5.1.3 Global Image-based FFR Diagnosis Sales Value by Region (2025-2030)
5.1.4 Global Image-based FFR Diagnosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Image-based FFR Diagnosis Sales Value, 2019-2030
5.2.2 North America Image-based FFR Diagnosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Image-based FFR Diagnosis Sales Value, 2019-2030
5.3.2 Europe Image-based FFR Diagnosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Image-based FFR Diagnosis Sales Value, 2019-2030
5.4.2 Asia Pacific Image-based FFR Diagnosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Image-based FFR Diagnosis Sales Value, 2019-2030
5.5.2 South America Image-based FFR Diagnosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Image-based FFR Diagnosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Image-based FFR Diagnosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Image-based FFR Diagnosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Image-based FFR Diagnosis Sales Value
6.3 United States
6.3.1 United States Image-based FFR Diagnosis Sales Value, 2019-2030
6.3.2 United States Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Image-based FFR Diagnosis Sales Value, 2019-2030
6.4.2 Europe Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Image-based FFR Diagnosis Sales Value, 2019-2030
6.5.2 China Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Image-based FFR Diagnosis Sales Value, 2019-2030
6.6.2 Japan Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Image-based FFR Diagnosis Sales Value, 2019-2030
6.7.2 South Korea Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Image-based FFR Diagnosis Sales Value, 2019-2030
6.8.2 Southeast Asia Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Image-based FFR Diagnosis Sales Value, 2019-2030
6.9.2 India Image-based FFR Diagnosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Image-based FFR Diagnosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 HeartFlow
7.1.1 HeartFlow Profile
7.1.2 HeartFlow Main Business
7.1.3 HeartFlow Image-based FFR Diagnosis Products, Services and Solutions
7.1.4 HeartFlow Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.1.5 HeartFlow Recent Developments
7.2 Medis QFR
7.2.1 Medis QFR Profile
7.2.2 Medis QFR Main Business
7.2.3 Medis QFR Image-based FFR Diagnosis Products, Services and Solutions
7.2.4 Medis QFR Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.2.5 Medis QFR Recent Developments
7.3 Beijing Heart Century
7.3.1 Beijing Heart Century Profile
7.3.2 Beijing Heart Century Main Business
7.3.3 Beijing Heart Century Image-based FFR Diagnosis Products, Services and Solutions
7.3.4 Beijing Heart Century Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.3.5 RainMed Recent Developments
7.4 RainMed
7.4.1 RainMed Profile
7.4.2 RainMed Main Business
7.4.3 RainMed Image-based FFR Diagnosis Products, Services and Solutions
7.4.4 RainMed Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.4.5 RainMed Recent Developments
7.5 AITROX
7.5.1 AITROX Profile
7.5.2 AITROX Main Business
7.5.3 AITROX Image-based FFR Diagnosis Products, Services and Solutions
7.5.4 AITROX Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.5.5 AITROX Recent Developments
7.6 Keya Medical
7.6.1 Keya Medical Profile
7.6.2 Keya Medical Main Business
7.6.3 Keya Medical Image-based FFR Diagnosis Products, Services and Solutions
7.6.4 Keya Medical Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.6.5 Keya Medical Recent Developments
7.7 Beijing GuanShengYun
7.7.1 Beijing GuanShengYun Profile
7.7.2 Beijing GuanShengYun Main Business
7.7.3 Beijing GuanShengYun Image-based FFR Diagnosis Products, Services and Solutions
7.7.4 Beijing GuanShengYun Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.7.5 Beijing GuanShengYun Recent Developments
7.8 ShengShi
7.8.1 ShengShi Profile
7.8.2 ShengShi Main Business
7.8.3 ShengShi Image-based FFR Diagnosis Products, Services and Solutions
7.8.4 ShengShi Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.8.5 ShengShi Recent Developments
7.9 Shenzhen Escope Tech
7.9.1 Shenzhen Escope Tech Profile
7.9.2 Shenzhen Escope Tech Main Business
7.9.3 Shenzhen Escope Tech Image-based FFR Diagnosis Products, Services and Solutions
7.9.4 Shenzhen Escope Tech Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.9.5 Shenzhen Escope Tech Recent Developments
7.10 Pulse Medical Imaging
7.10.1 Pulse Medical Imaging Profile
7.10.2 Pulse Medical Imaging Main Business
7.10.3 Pulse Medical Imaging Image-based FFR Diagnosis Products, Services and Solutions
7.10.4 Pulse Medical Imaging Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.10.5 Pulse Medical Imaging Recent Developments
7.11 Shukun
7.11.1 Shukun Profile
7.11.2 Shukun Main Business
7.11.3 Shukun Image-based FFR Diagnosis Products, Services and Solutions
7.11.4 Shukun Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.11.5 Shukun Recent Developments
7.12 Raysight
7.12.1 Raysight Profile
7.12.2 Raysight Main Business
7.12.3 Raysight Image-based FFR Diagnosis Products, Services and Solutions
7.12.4 Raysight Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.12.5 Raysight Recent Developments
7.13 Cathworks
7.13.1 Cathworks Profile
7.13.2 Cathworks Main Business
7.13.3 Cathworks Image-based FFR Diagnosis Products, Services and Solutions
7.13.4 Cathworks Image-based FFR Diagnosis Revenue (US$ Million) & (2019-2024)
7.13.5 Cathworks Recent Developments
8 Industry Chain Analysis
8.1 Image-based FFR Diagnosis Industrial Chain
8.2 Image-based FFR Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Image-based FFR Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Image-based FFR Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
HeartFlow
Medis QFR
Beijing Heart Century
RainMed
AITROX
Keya Medical
Beijing GuanShengYun
ShengShi
Shenzhen Escope Tech
Pulse Medical Imaging
Shukun
Raysight
Cathworks
Ìý
Ìý
*If Applicable.
